Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.

Kaido T, Yoda M, Kamijo T, Taira C, Higuchi Y, Okumura N.

Int J Lab Hematol. 2020 Apr;42(2):190-197. doi: 10.1111/ijlh.13152. Epub 2020 Jan 20.

PMID:
31957968
2.

Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia.

Saito S, Taira C, Matsuda K, Yanagisawa R, Morita D, Shigemura T, Yoshikawa K, Tanaka M, Sakashita K, Mukai S, Shimodaira S, Koike K, Nakazawa Y.

Leuk Lymphoma. 2020 Apr;61(4):967-970. doi: 10.1080/10428194.2019.1697813. Epub 2019 Dec 6. No abstract available.

PMID:
31809628
3.

γD318Y fibrinogen shows no fibrin polymerization due to defective "A-a" and "B-b" interactions, whereas that of γK321E fibrinogen is nearly normal.

Kamijo T, Mukai S, Taira C, Higuchi Y, Okumura N.

Thromb Res. 2019 Oct;182:150-158. doi: 10.1016/j.thromres.2019.08.017. Epub 2019 Aug 20.

PMID:
31484085
4.

Fibrin monomers derived from thrombogenic dysfibrinogenemia, Naples-type variant (BβAla68Thr), showed almost entirely normal polymerization.

Kamijo T, Nagata K, Taira C, Higuchi Y, Arai S, Okumura N.

Thromb Res. 2018 Dec;172:1-3. doi: 10.1016/j.thromres.2018.10.004. Epub 2018 Oct 4. No abstract available.

PMID:
30321757
5.

A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia.

Taira C, Matsuda K, Arai S, Sugano M, Uehara T, Okumura N.

Int J Mol Sci. 2017 Nov 20;18(11). pii: E2470. doi: 10.3390/ijms18112470.

6.

A novel frameshift mutation in the fibrinogen γC terminal region, FGG c.1169_1170 del AT, leading to hypofibrinogenemia.

Nagata K, Arai S, Taira C, Sugano M, Honda T, Okumura N.

Thromb Res. 2017 Nov;159:82-85. doi: 10.1016/j.thromres.2017.10.002. Epub 2017 Oct 2. No abstract available.

PMID:
28992465
7.

Rapid ABO genotyping by high-speed droplet allele-specific PCR using crude samples.

Taira C, Matsuda K, Takeichi N, Furukawa S, Sugano M, Uehara T, Okumura N, Honda T.

J Clin Lab Anal. 2018 Jan;32(1). doi: 10.1002/jcla.22196. Epub 2017 Mar 13.

8.

Development of a rapid and sensitive one-step reverse transcription-nested polymerase chain reaction in a single tube using the droplet-polymerase chain reaction machine.

Yamaguchi A, Matsuda K, Sueki A, Taira C, Uehara M, Saito Y, Honda T.

Clin Chim Acta. 2015 Aug 25;448:150-4. doi: 10.1016/j.cca.2015.07.003. Epub 2015 Jul 3.

PMID:
26148723
9.

Rapid single nucleotide polymorphism based method for hematopoietic chimerism analysis and monitoring using high-speed droplet allele-specific PCR and allele-specific quantitative PCR.

Taira C, Matsuda K, Yamaguchi A, Uehara M, Sugano M, Okumura N, Honda T.

Clin Chim Acta. 2015 May 20;445:101-6. doi: 10.1016/j.cca.2015.03.018. Epub 2015 Mar 20.

PMID:
25797898
10.

Epithelial-mesenchymal transition of A549 cells is enhanced by co-cultured with THP-1 macrophages under hypoxic conditions.

Sueki A, Matsuda K, Iwashita C, Taira C, Ishimine N, Shigeto S, Kawasaki K, Sugano M, Yamamoto H, Honda T.

Biochem Biophys Res Commun. 2014 Oct 31;453(4):804-9. doi: 10.1016/j.bbrc.2014.10.022. Epub 2014 Oct 14.

PMID:
25445593
11.

STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia.

Ishida F, Matsuda K, Sekiguchi N, Makishima H, Taira C, Momose K, Nishina S, Senoo N, Sakai H, Ito T, Kwong YL.

Cancer Sci. 2014 Mar;105(3):342-6. doi: 10.1111/cas.12341. Epub 2014 Jan 22.

12.

Novel high-speed droplet-allele specific-polymerase chain reaction: application in the rapid genotyping of single nucleotide polymorphisms.

Taira C, Matsuda K, Yamaguchi A, Sueki A, Koeda H, Takagi F, Kobayashi Y, Sugano M, Honda T.

Clin Chim Acta. 2013 Sep 23;424:39-46. doi: 10.1016/j.cca.2013.04.024. Epub 2013 May 17.

PMID:
23685227
13.

Rapid detection of PML-RARA fusion gene by novel high-speed droplet-reverse transcriptase-polymerase chain reaction: possibility for molecular diagnosis without lagging behind the morphological analyses.

Sueki A, Matsuda K, Taira C, Yamaguchi A, Koeda H, Takagi F, Kobayashi Y, Sugano M, Honda T.

Clin Chim Acta. 2013 Jan 16;415:276-8. doi: 10.1016/j.cca.2012.10.059. Epub 2012 Nov 13.

PMID:
23159843
14.

Spliceosome-related gene mutations in myelodysplastic syndrome can be used as stable markers for monitoring minimal residual disease during follow-up.

Matsuda K, Ishida F, Ito T, Nakazawa H, Miura S, Taira C, Sueki A, Kobayashi Y, Honda T.

Leuk Res. 2012 Nov;36(11):1393-7. doi: 10.1016/j.leukres.2012.07.019. Epub 2012 Aug 14.

PMID:
22902051
15.

A novel high-speed droplet-polymerase chain reaction can detect human influenza virus in less than 30 min.

Matsuda K, Yamaguchi A, Taira C, Sueki A, Koeda H, Takagi F, Sugano M, Honda T.

Clin Chim Acta. 2012 Nov 12;413(21-22):1742-5. doi: 10.1016/j.cca.2012.06.026. Epub 2012 Jun 29.

PMID:
22750331
16.

[Case with intrauterine fetus death: interphase fluorescence in situ hybridization using buccal cells is useful for examining chromosomal abnormalities when placental villus not available].

Takezawa Y, Kosho T, Matsuda K, Taira C, Ito Y, Hidaka E, Sugano M, Narumi Y, Mizuuchi A, Kobara H, Wakui K, Okumura N, Fukushima Y, Honda T.

Rinsho Byori. 2012 Jan;60(1):32-6. Japanese.

PMID:
22416454
18.

Genetic analysis of TP53 in childhood myelodysplastic syndrome and juvenile myelomonocytic leukemia.

Saito S, Matsuda K, Taira C, Sano K, Tanaka-Yanagisawa M, Yanagisawa R, Nakazawa Y, Sakashita K, Shiohara M, Koike K.

Leuk Res. 2011 Dec;35(12):1578-84. doi: 10.1016/j.leukres.2011.06.027. Epub 2011 Jul 23.

PMID:
21784522
19.

[Development of multiplex short tandem repeat (STR)-PCR for chimerism analysis in patients with hematological malignancies and comparison of chimerism in different sample sources].

Taira C, Matsuda K, Takezawa Y, Ito T, Ishida F, Hidaka E, Kumagai T, Honda T.

Rinsho Byori. 2011 Jan;59(1):24-30. Japanese.

PMID:
21404576
20.

Quantitative monitoring of single nucleotide mutations by allele-specific quantitative PCR can be used for the assessment of minimal residual disease in patients with hematological malignancies throughout their clinical course.

Taira C, Matsuda K, Kamijyo Y, Sakashita K, Ishida F, Kumagai T, Yamauchi K, Okumura N, Honda T.

Clin Chim Acta. 2011 Jan 14;412(1-2):53-8. doi: 10.1016/j.cca.2010.09.011. Epub 2010 Sep 16.

PMID:
20849840

Supplemental Content

Loading ...
Support Center